← FDA DRUG APPROVALS

FDA ANDA · ANDA203725

VECURONIUM BROMIDE

Sponsor: HIKMA

APPLICATION
ANDA203725
TYPE
ANDA
ORIGINAL APPROVAL
2019-07-30
LATEST ACTION
2025-12-09
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

VECURONIUM BROMIDEPrescription
VECURONIUM BROMIDE 10MG/VIAL · INJECTABLE · INJECTION
VECURONIUM BROMIDEPrescription
VECURONIUM BROMIDE 20MG/VIAL · INJECTABLE · INJECTION

Approval history

2025-12-09Labeling · Supplement 4 · standardAP
2019-07-30UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →